Guggenheim Remains Positive on Phibro Animal Health (PAHC), Raises Price Target to $40
Guggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
